Simplex Trading’s Tonix Pharmaceuticals TNXP Stock Holding History

Simplex Trading’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$122K	Buy	+8,900	New	+$137K	﹤0.01%	4850
2025 Q4	–	Sell	-2,800	Closed	-$67K	–	10084
2025 Q3	$67K	Buy	+2,800	New	+$104K	﹤0.01%	6157
2016 Q1	–	Hold	0	–	-$4K	–	6250
2015 Q4	–	Hold	0	–	–	–	4072
2015 Q3	–	Hold	0	–	-$8K	–	6200
2015 Q2	–	Hold	0	–	–	–	3280
2015 Q1	–	Hold	0	–	–	–	3250

Other funds holding TNXP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JHC

Jones Hill Capital New York $466M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Simplex Trading's TNXP Position: Q1 2026 in Review

Simplex Trading opened a new position in Tonix Pharmaceuticals (TNXP) in Q1 2026: 5,108 shares worth $70.2K. The stake represents ﹤0.01% of the portfolio and ranks #5491 among its holdings.

81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

Simplex Trading held 5,108 shares of Tonix Pharmaceuticals worth $70.2K as of Q1 2026.
Tonix Pharmaceuticals was a new Simplex Trading position in Q1 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5491 holding.
81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.